Free Trial

Asensus Surgical Q3 2023 Earnings Report

Asensus Surgical logo
$0.35 0.00 (0.00%)
As of 08/22/2024

Asensus Surgical EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.07
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Asensus Surgical Revenue Results

Actual Revenue
$1.09 million
Expected Revenue
$1.50 million
Beat/Miss
Missed by -$410.00 thousand
YoY Revenue Growth
N/A

Asensus Surgical Announcement Details

Quarter
Q3 2023
Time
N/A

Asensus Surgical Earnings Headlines

Market down? Do this now.
The Trump administration's new tariffs have already begun to shake the economy. The impact is real, and the clock is ticking. If you don't act now, your savings could be in serious jeopardy. At Colonial Metals, we're here to help you take control of your financial future. That's why we've created a FREE Wealth Protection Guide to show you how to protect your wealth during these uncertain times.
See More Asensus Surgical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Asensus Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Asensus Surgical and other key companies, straight to your email.

About Asensus Surgical

Asensus Surgical (NYSEAMERICAN:ASXC), a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

View Asensus Surgical Profile

More Earnings Resources from MarketBeat